| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 412.6 | 433.6 | 297.6 |
| Other income | 0.8 | 1.7 | 0.5 |
| Total income | 413.4 | 435.4 | 298.2 |
| Profit before exceptional items & tax | 49.9 | 83.6 | 23.2 |
| Profit before tax | 49.9 | 83.6 | 23.2 |
| Net profit | 38.0 | 61.0 | 17.1 |
| Operating margin | 12.1% | 19.2% | 7.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +122.20% |
|---|---|
| Net profit, quarter on quarter | -37.70% |
| Revenue, year on year | +38.60% |
| Operating profit, year on year | +116.30% |
| Operating profit, quarter on quarter | -40.00% |
BSE results filing, NSE: PRASOLCHEM. Figures extracted from the filing.
Prasol Chemicals Ltd: key numbers
- Share price
- ₹817.25
- Market cap
- ₹4,837 Cr
- Revenue (annual)
- ₹1,233 Cr
- Net profit (annual)
- ₹83.12 Cr
- Promoter holding
- 75.25%
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prasol Chemicals Ltd
All →Prasol Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs412.6cr (+38.6% YoY), PAT Rs37.9cr (+122.2%), EBITDA margin 14.0%. H1 FY27 revenue Rs846.2cr (+37.1%), highest-ever Q2.
Prasol Chemicals Board Meeting Date
Prasol Chemicals gives prior intimation of a board meeting on 2 November 2026 to consider unaudited results for the quarter and half year ended September 2026. The trading window remains closed until 48 hours after the results.
Prasol Chemicals Other Announcement
Prasol Chemicals Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Prasol Chemicals Other Announcement
Prasol Chemicals Limited updated its Corporate Identification Number (CIN) from "U99999MH1992PLC065026" to "L99999MH1992PLC065026" following its recent equity listing.
Prasol Chemicals Earnings Call Transcript: Key Takeaways
Prasol Chemicals reported record Q1 FY27 performance with revenue up 36% YoY. Strategy focuses on expanding high-margin acetone and phosphorus derivatives via massive capex and R&D.
- Call
- Guides 26% growth
Prasol Chemicals Investor Presentation: Key Takeaways
Prasol Chemicals reported record Q1FY27 performance following its Sep 2026 IPO, driven by volume growth and improved product mix in Acetone and Phosphorus derivatives.
- Call
- Guides 143% growth